Live Breaking News & Updates on Cymabay Therapeutic New Drug Application

Stay updated with breaking news from Cymabay therapeutic new drug application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

RESPONSE: Seladelpar Normalizes Alkaline Phosphatase, Reduces Pruritus in PBC

Results from the phase 3 trial showed seladelpar elicited biochemical response, normalized alkaline phosphatase, and reduced pruritus at a greater rate than placebo. ....

David Assis , Terry Horner , Gideon Hirschfield , Yale School Of Medicine , Autoimmune Liver Disease Research , Drug Administration , University Of Toronto , Foundation Gideon Hirschfield , New England Journal , Yale School , Cymabay Therapeutic New Drug Application , Priority Review , Prescription Drug User Fee Act , Terry Horner Chair , Primary Biliary , Improves Markers , Second Line Treatment , Primary Biliary Cholangitis , Biochemical Response , Alkaline Phosphatase , Ursodeoxycholic Acid , Obeticholic Acid ,